Tales From the Road

Biotech and MedTech Innovators on their Fundraising Journey

Wednesday (3/15) – 1 PM EDT

The industry has quickly adapted to a “new normal” – entrepreneurs and investors meet virtually over digital platforms to discuss potential investment opportunities, and it is not uncommon to see entrepreneurs raise capital from investors they have never met before in person. That said, there is no doubt that the fundraising journey continues to be challenging for many. In this panel, you will be able to hear fellow entrepreneurs share their experiences, from successes to challenges. This panel will discuss the following topics and more:

  • What are some of the greatest challenges entrepreneurs have faced, especially during the pandemic, and how were they overcome?
  • How did entrepreneurs identify investors that fit their technology?
  • What are some misconceptions entrepreneurs had about the early-stage investment landscape?

Furthermore, entrepreneurs will share unique tips and insights they have gained from their fundraising experiences, and how others can work their way towards a more successful campaign.


Greg Mannix, VP of International Business Development, Life Science Nation (Moderator)

Greg Mannix is Vice President of International Business Development at Life Science Nation. After graduating from the University of California, he moved to Europe where he began a career in the life sciences and obtained a Master’s degree from IE Business School in Madrid. He has extensive experience in sales and marketing management in large medical device corporations and small start-ups alike, giving Greg a well-rounded international experience in the healthcare field. He has worked extensively in Europe, North America and Latin America and he speaks English, Spanish and French.

Greg relocated to Boston 6 years ago to set up the US affiliate for an early-stage Med-tech company from Spain and he immediately took to the vibrant startup community there. Working for LSN is a great way to stay involved in that exciting space.

Diana Caldwell, CEO, Amplified Sciences

Diana Caldwell is the President, CEO and co-founder of Amplified Sciences, a startup life science diagnostics company focused on accurately detecting and pre-empting the risks of debilitating diseases, including lethal cancers with R&D operations in Purdue Research Park. She is a recognized life science entrepreneur with over 25 years of experience in both large corporate and small entrepreneurial environments. Throughout her career, she has successfully driven organizational growth, developed and implemented strategic business plans, and directed successful teams.

Early in her career, she worked for Eli Lilly for over 15 years in a variety of general management roles.

Diana founded Pensar Ideas which is a business consultancy practice focused on business planning and strategy, business operations support, and commercialization strategy and support for life science companies. She also served as an Entrepreneur in Residence for the Purdue Foundry startup community.

In 2010, Diana co-founded Pearl Pathways where she led the company as President and CEO and oversaw all business operations, business development, legal, and financial functions.

Diana serves on the Board of Directors for Genezen and also lends her talents to several community organizations and not-for-profits including IHIF, IU Kelley School’s Life Sciences Advisory Board, The ARC of Indiana Foundation, and Senator Lugar’s Fund for Hoosier Excellence.

Specialties: Leadership, Business Strategy, Commercialization Strategy, Life science product development, Diagnostics, IVD, medical devices, Pharmaceuticals, Biologics, Regulatory approval processes, Quality compliance systems, Clinical research, Clinical trials, IRB, Business Planning, Marketing, Sales, Business Development, Operations, Financial modelling, General Management